A new impact framework for investors in life sciences bridges financial returns and patient outcomes
Crossref DOI link: https://doi.org/10.1038/s41587-025-02726-5
Published Online: 2025-07-15
Published Print: 2025-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Brainin, Philip https://orcid.org/0000-0001-6880-0424
Text and Data Mining valid from 2025-07-01
Version of Record valid from 2025-07-01
Article History
First Online: 15 July 2025
Competing interests
: The author declares no competing interests.